HKPD

Cellyan Biotechnology Co., Ltd Class A Ordinary Shares

HKPD
Closed
$0.45
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

Cellyan Biotechnology Ltd. engages in providing pharmaceutical cross-border e-commerce supply chain services. The company employs 27 full-time employees The company went IPO on 2025-01-15. The firm mainly provides two services. The supply chain services mainly provide OTC pharmaceutical cross-border e-commerce supply chain services. The procurement and distribution services mainly provide OTC pharmaceutical cross-border procurement and distribution services.
Country

HK

CEO

Mr. Chenyu Liang

IPO date

2025

Employees

27

ISIN

KYG6365B1041

Website

www.9zt.hk

Key stats

Open

$0.47

Volume

164.61K

Market cap

$4.98M

Prev. close

$0.45

Impl / hst vl

-

Open interest

$0.00

$0.44

Day’s Range

$0.53

$0.32

52W Range

$0.90

Valuation

33
Valuation score
Overvalued
P/E
-
P/S
-
P/B
-
Current ratio
-
Debt / Equity
-
ROE
-
Gross margin
-
Income growth
-667.16%
FCF growth
-

Analysts estimates

Earnings

Q3 ‘25 revenue
$7.14M
Q3 ‘25 net income
$153.70K
Revenue
Net income
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply